Sort   by:  
 Page size 
We presented the pharmacodynamic relationship between benzoxaborole concentrations and Candida albians blastoconidial population dynamics. Bis(benzoxaborole) analogue (2) and Tavaborole (ref.) showed comparable moderate effects against C. albicans (time-kill kinetic assays). Benzoxaboroles inhibited...
ORGANISM(S): Candida albicans 
2026-04-30 | GSE296032 | GEO
Wild type T. brucei bloodstream form were incubated with increasing concentrations of AN7973, a benzoxaborole compound developed by Anacor Pharmaceuticals Inc. against Animal African Trypanosomiasis. Cells had a tendency to lose resistance, only roughly 2x EC50 resistance was obtained. This experime...
ORGANISM(S): Trypanosoma brucei brucei 
On the mode of anti-C. albicans activity of a bis(benzoxaborole) analogue of Tavaborole
Trypanosoma brucei transcriptome changes upon exposure to the aminomethyl-benzoxaborole AN3057
Recent development of benzoxaborole-based chemistry gave rise to a collection of compounds with great potential in targeting diverse infectious diseases, including human African Trypanosomiasis (HAT), a devastating neglected tropical disease. However, further medicinal development is largely restric...
2018-02-12 | MTBLS452 | MetaboLights
Sort   by:  
 Page size